We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cboe Global (CBOE) to Report Q3 Earnings: Is a Beat in Store?
Read MoreHide Full Article
Cboe Global Markets (CBOE - Free Report) is slated to report third-quarter 2019 results on Nov 1, before market open. The company delivered positive earnings surprise in the last two reported quarters of 2019.
Let’s see how things have shaped up for this announcement.
Cboe Global’s third-quarter performance is likely to have benefited from strong market position and strength in its proprietary products, primarily SPX options, VIX options and VIX futures.
Acquisition of Bats Global is likely to have aided non-transactional revenue generating avenues.
Third-quarter revenues are expected to have benefited from proprietary market data and access and capacity fees. The Zacks Consensus Estimate for revenues is pegged at $284.2 million, indicating 5.1% increase from year-ago reported quarter figure.
CBOE Global estimates revenue per contract (RPC) for total options for the third quarter of 2019 to be 1% to 2% lower than 24.10 cents for the two months ended Aug 31, 2019. The RPC for futures is projected to be 0.5% to 1% higher than the two-month average of $1.783, indicating lower volume-related rebates in September.
Expenses are likely to have increased given several ongoing investments in systems hardware and software.
The Zacks Consensus Estimate for earnings is pegged at $1.15, indicating 5.2% increase from the year-ago period reported figure.
Our proven model predicts an earnings beat for Cboe Global this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat.
Earnings ESP: Cboe Global has an Earnings ESP of +0.72%. This is because the Most Accurate Estimate of $1.16 is pegged higher than the Zacks Consensus Estimate of $1.15. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Cboe Global carries a Zacks Rank #3.
Other Stocks to Consider
Here are some other stocks from the finance sector with the perfect combination of elements to surpass estimates in their upcoming releases.
Brighthouse Financial (BHF - Free Report) is set to report third-quarter earnings on Nov 4. The stock has an Earnings ESP of +0.56% and a Zacks Rank #3.
Ares Management L.P. (ARES - Free Report) is set to report third-quarter earnings on Oct 31. The stock has an Earnings ESP of +3.36% and a Zacks Rank of 3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Cboe Global (CBOE) to Report Q3 Earnings: Is a Beat in Store?
Cboe Global Markets (CBOE - Free Report) is slated to report third-quarter 2019 results on Nov 1, before market open. The company delivered positive earnings surprise in the last two reported quarters of 2019.
Let’s see how things have shaped up for this announcement.
Cboe Global’s third-quarter performance is likely to have benefited from strong market position and strength in its proprietary products, primarily SPX options, VIX options and VIX futures.
Acquisition of Bats Global is likely to have aided non-transactional revenue generating avenues.
Third-quarter revenues are expected to have benefited from proprietary market data and access and capacity fees. The Zacks Consensus Estimate for revenues is pegged at $284.2 million, indicating 5.1% increase from year-ago reported quarter figure.
CBOE Global estimates revenue per contract (RPC) for total options for the third quarter of 2019 to be 1% to 2% lower than 24.10 cents for the two months ended Aug 31, 2019. The RPC for futures is projected to be 0.5% to 1% higher than the two-month average of $1.783, indicating lower volume-related rebates in September.
Expenses are likely to have increased given several ongoing investments in systems hardware and software.
The Zacks Consensus Estimate for earnings is pegged at $1.15, indicating 5.2% increase from the year-ago period reported figure.
Cboe Global Markets, Inc. Price and EPS Surprise
Cboe Global Markets, Inc. price-eps-surprise | Cboe Global Markets, Inc. Quote
What Our Quantitative Model States
Our proven model predicts an earnings beat for Cboe Global this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat.
Earnings ESP: Cboe Global has an Earnings ESP of +0.72%. This is because the Most Accurate Estimate of $1.16 is pegged higher than the Zacks Consensus Estimate of $1.15. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Cboe Global carries a Zacks Rank #3.
Other Stocks to Consider
Here are some other stocks from the finance sector with the perfect combination of elements to surpass estimates in their upcoming releases.
Intercontinental Exchange (ICE - Free Report) is set to report third-quarter earnings on Oct 31. The stock has an Earnings ESP of +0.07% and a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Brighthouse Financial (BHF - Free Report) is set to report third-quarter earnings on Nov 4. The stock has an Earnings ESP of +0.56% and a Zacks Rank #3.
Ares Management L.P. (ARES - Free Report) is set to report third-quarter earnings on Oct 31. The stock has an Earnings ESP of +3.36% and a Zacks Rank of 3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>